NPR logo

Listen to this 'Talk of the Nation' topic

  • Download
  • <iframe src="https://www.npr.org/player/embed/12352782/12352783" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
FDA Drug Approval Comes Too Late for Many Patients

Health

FDA Drug Approval Comes Too Late for Many Patients

Listen to this 'Talk of the Nation' topic

  • Download
  • <iframe src="https://www.npr.org/player/embed/12352782/12352783" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

For many patients dying of cancer, their last chance at survival may not yet be an option. Experimental drugs often take years to approve, and in the testing phase they are only available to a tiny group of patients. Do patients have a constitutional right to try experimental drugs?

Frank Burroughs, president, Abigail Alliance for Better Access to Developmental Drugs

Frances Miller, professor of law, Boston University School of Law

Dr. Emil Freireich, director, Adult Leukemia Research Program, University of Texas M.D. Anderson Cancer Center

Dr. Ezekiel Emanuel, chair of the Department of Bioethics for The Clinical Center at the National Institutes of Health